Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer

1. Martín, M.
2. González-Rivera, M.
3. Morales, S.
4. De La Haba-Rodriguez, J.
5. González-Cortijo, L.
6. Manso, L.
7. Albanell, J.
8. González-Martín, A.
9. González, S.
10. Arcusa, A.
11. De La Cruz-Merino, L.
12. Rojo, F.
13. Vidal, M.
14. Galván, P.
15. Aguirre, E.
16. Morales, C.
17. Ferree, S.
18. Pompilio, K.
19. Casas, M.
20. Caballero, R.
21. Goicoechea, U.
22. Carrasco, E.
23. Michalopoulos, S.
24. Hornberger, J.
25. Prat, A.